Literature DB >> 24854896

Permeability comparison between hepatocyte and low efflux MDCKII cell monolayer.

Rui Li1, Yi-An Bi, Yurong Lai, Kiyohiko Sugano, Stefanus J Steyn, Patrick E Trapa, Li Di.   

Abstract

Determination of passive permeability is not only important for predicting oral absorption and brain penetration, but also for accurately predicting hepatic clearance. High throughput (HT) measurement of passive permeability across hepatocyte cell membrane is technically more challenging than using monolayer cell-based permeability assays. In this study, we evaluated if the HT Madin-Darby canine kidney II-low efflux (MDCKII-LE) cell monolayer permeability assay can be used as a surrogate to predict the passive permeability of hepatocytes. Apparent passive permeability of MDCKII-LE is well correlated to passive diffusion clearance of human and rat hepatocytes, suggesting that the HT MDCKII-LE assay can be used as a surrogate to estimate the passive permeability of hepatocytes. In addition, lipophilicity (Log D determined at pH 7.4) was also found to be well correlated with both MDCKII-LE and hepatocyte permeability for most compounds, hence it may serve as another permeability surrogate.

Entities:  

Mesh:

Year:  2014        PMID: 24854896      PMCID: PMC4070250          DOI: 10.1208/s12248-014-9616-5

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  23 in total

1.  Characterization of digoxin uptake in sandwich-cultured human hepatocytes.

Authors:  Emi Kimoto; Jonathan Chupka; Yongling Xiao; Yi-An Bi; David B Duignan
Journal:  Drug Metab Dispos       Date:  2010-10-06       Impact factor: 3.922

2.  Measurement of plasma membrane potential in isolated rat hepatocytes using the lipophilic cation, tetraphenylphosphonium: correction of probe intracellular binding and mitochondrial accumulation.

Authors:  S Saito; Y Murakami; S Miyauchi; N Kamo
Journal:  Biochim Biophys Acta       Date:  1992-11-09

Review 3.  Transporters as a determinant of drug clearance and tissue distribution.

Authors:  Yoshihisa Shitara; Toshiharu Horie; Yuichi Sugiyama
Journal:  Eur J Pharm Sci       Date:  2006-02-20       Impact factor: 4.384

Review 4.  Introduction to computational oral absorption simulation.

Authors:  Kiyohiko Sugano
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-03       Impact factor: 4.481

5.  Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data.

Authors:  Agnès Poirier; Anne-Christine Cascais; Christoph Funk; Thierry Lavé
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-11-20       Impact factor: 2.745

6.  Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.

Authors:  Renata M Oballa; Liette Belair; W Cameron Black; Kelly Bleasby; Chi Chung Chan; Carole Desroches; Xiaobing Du; Robert Gordon; Jocelyne Guay; Sebastien Guiral; Michael J Hafey; Emelie Hamelin; Zheng Huang; Brian Kennedy; Nicolas Lachance; France Landry; Chun Sing Li; Joseph Mancini; Denis Normandin; Alessandro Pocai; David A Powell; Yeeman K Ramtohul; Kathryn Skorey; Dan Sørensen; Wayne Sturkenboom; Angela Styhler; Deena M Waddleton; Hao Wang; Simon Wong; Lijing Xu; Lei Zhang
Journal:  J Med Chem       Date:  2011-06-28       Impact factor: 7.446

Review 7.  Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics.

Authors:  M Yamazaki; H Suzuki; Y Sugiyama
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

Review 8.  Application of physiologically based pharmacokinetic modeling and clearance concept to drugs showing transporter-mediated distribution and clearance in humans.

Authors:  Takao Watanabe; Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-10       Impact factor: 2.745

9.  Is 1-aminobenzotriazole an appropriate in vitro tool as a nonspecific cytochrome P450 inactivator?

Authors:  Collette D Linder; Nicole A Renaud; J Matthew Hutzler
Journal:  Drug Metab Dispos       Date:  2008-10-20       Impact factor: 3.922

10.  Modulation of the partition coefficient between octanol and buffer at pH 7.4 and pKa to achieve the optimum balance of blood clearance and volume of distribution for a series of tetrahydropyran histamine type 3 receptor antagonists.

Authors:  Tanya Hay; Rhys Jones; Kevin Beaumont; Mark Kemp
Journal:  Drug Metab Dispos       Date:  2009-06-22       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.